Stuttgart - Delayed Quote EUR

Seres Therapeutics Inc (1S9.SG)

Compare

0.8408

+0.0048

+(0.57%)

At close: January 24 at 5:43:39 PM GMT+1

No Tool

Measure

UNDO

Redo

All

Favorites

Text

Statistics

Technicals

Fibonacci

Markings

Lines

Annotation

Arrow

Line

Horizontal

Vertical

Rectangle

Trend Line

Measurement Line

Average Line

Callout

Channel

Check

Continuous

Crossline

Elliott Wave

Ellipse

Doodle

Fib Projection

Fib Arc

Fib Fan

Fib Time Zone

Focus

Gann Fan

Gartley

Heart

Pitchfork

Quadrant Lines

Ray

Regression Line

Fib Retracement

Star

Speed Resistance Arc

Speed Resistance Line

Time Cycle

Tirone Levels

Volume Profile

Cross

Loading Chart for 1S9.SG

Seres Therapeutics Announces Receipt of Expected $50 Million Installment Payment Related to VOWST Sale

Seres announces new translational biomarker results from SER-155 Phase 1b study

Seres Therapeutics Announces New Translational Biomarker Results from SER-155 Phase 1b Clinical Study and Provides Corporate Updates

The past three years for Seres Therapeutics (NASDAQ:MCRB) investors has not been profitable

Seres Therapeutics to highlight plans for SER-155 at JPMorgan conference

Seres Therapeutics to Participate in 2025 J.P. Morgan Healthcare Conference

Seres’ SER-155 gains breakthrough status for BSIs reduction

FDA Grants Breakthrough Therapy Designation to Seres Therapeutics’ SER-155 for Reduction of Bloodstream Infections in Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT)

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Seres Therapeutics Inc (1S9.SG)

Comparisons

Indicators

Technicals

Corporate Events

19.57%

-9.16%

16.94%

-19.85%

1.72%

-24.25%

-73.72%

-92.40%

Recent News: 1S9.SG